乳腺肿瘤；雌激素受体；孕激素受体；cerbB2_

乳腺癌ER，PR，cerbB2表达与临床病理特征的相关性分析

http://www.100md.com 《第四军医大学学报》 2006年第17期

乳腺肿瘤；雌激素受体；孕激素受体；cerbB2,,乳腺肿瘤；雌激素受体；孕激素受体；cerbB2,0引言,1材料和方法

     Correlation of expressions of ER, PR and cerbB2 to clinicopathologic factors in breast cancer

    CHEN Ling, LI Xu, ZHAO XinHan

    Department of Oncology, First Affiliated Hospital, Medical College, Xian Jiaotong University, Xian 710061, China

    【Abstract】 AIM: To analyze the expressions of ER, PR, cerbB2 and to explore the correlation of the expressions to clinicopathologic factors in breast cancer and the relation among the expressions themselves. METHODS: Ninety patients with breast cancer who were treated in our hospital from May, 2004 to May, 2005 were analyzed retrospectively. Expressions of ER, PR, cerbB2 were detected by immunohistochemistry in the 90 patients with breast cancer. Correlation of expressions of ER, PR, cerbB2 to patients age, tumor size, position, lymph node metastasis, menses status and the relation among these three expressions were statistically analyzed. RESULTS: Of the 90 patients, 56 (62.22%) were ER positive, 52 (57.77%) PR positive ......

百拇医药网 http://www.100md.com/html/DirDu/2006/11/14/29/34/44.htm

您现在查看是摘要页，全文长 8267 字符。